Penumbra, Inc. designs, develops, manufactures, and markets a range of medical devices focused on neurovascular and vascular therapies. Its primary revenue comes from aspiration-based thrombectomy systems (approximately 40%), neurovascular embolization coiling systems (30%), and neurovascular access systems (20%), with the remaining 10% from other products such as neurosurgical tools and immersive technologies. Customers include hospitals, surgical centers, and healthcare providers in the United States and internationally. Factors supporting the company's endurance include a growing demand for minimally invasive procedures and advancements in medical technology, while potential limitations could arise from regulatory challenges and competition in the medical device sector.
—
Penumbra, Inc. designs, develops, manufactures, and markets a range of medical devices focused on neurovascular and vascular therapies. Its primary revenue comes from aspiration-based thrombectomy systems (approximately 40%), neurovascular embolization coiling systems (30%), and neurovascular access systems (20%), with the remaining 10% from other products such as neurosurgical tools and immersive technologies. Customers include hospitals, surgical centers, and healthcare providers in the United States and internationally. Factors supporting the company's endurance include a growing demand for minimally invasive procedures and advancements in medical technology, while potential limitations could arise from regulatory challenges and competition in the medical device sector.
—
Daily adjusted close
Penumbra, Inc. designs, develops, manufactures, and markets a range of medical devices focused on neurovascular and vascular therapies. Its primary revenue comes from aspiration-based thrombectomy systems (approximately 40%), neurovascular embolization coiling systems (30%), and neurovascular access systems (20%), with the remaining 10% from other products such as neurosurgical tools and immersive technologies. Customers include hospitals, surgical centers, and healthcare providers in the United States and internationally. Factors supporting the company's endurance include a growing demand for minimally invasive procedures and advancements in medical technology, while potential limitations could arise from regulatory challenges and competition in the medical device sector.